Inventor
MANTENA NARENDER DEV
IN15 patents
Patents
15 patentsUS11147863B2Oct 19, 2021
Multivalent pneumococcal conjugate vaccine
BIOLOGICAL E LTD2 citations66
US10836839B2Nov 17, 2020
Method for separation of protein and other impurities from microbial capsular polysaccharides
BIOLOGICAL E LTD2 citations65
US12276645B2Apr 15, 2025
Methods for quantification of carbohydrates
BIOLOGICAL E LTD0 citations59
US10280409B2May 7, 2019
Codon optimized polynucleotide for high level expression of CRM197
BIOLOGICAL E LTD1 citations59
US12318437B2Jun 3, 2025
Vaccine formulations comprising preservative
BIOLOGICAL E LTD0 citations57
US12465632B2Nov 11, 2025
Purified capsular polysaccharides of Streptococcus pneumoniae
BIOLOGICAL E LTD0 citations56
US12048739B2Jul 30, 2024
Purified capsular polysaccharides of Streptococcus pneumoniae
BIOLOGICAL E LTD0 citations56
US11725029B2Aug 15, 2023
Expression of pneumococcal surface protein a (PSPA)
BIOLOGICAL E LTD0 citations55
US11680111B2Jun 20, 2023
Method for separation of protein and other impurities from microbial capsular polysaccharides
BIOLOGICAL E LTD0 citations55
US11547752B2Jan 10, 2023
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
BIOLOGICAL E LTD1 citations53
US11098089B2Aug 24, 2021
Method for high level production of CRM197
BIOLOGICAL E LTD0 citations53
US11492421B2Nov 8, 2022
Process for the preparation of Dalteparin sodium
BIOLOGICAL E LTD0 citations52
US11420993B2Aug 23, 2022
Semi-synthetic meningococcal conjugate vaccine
BIOLOGICAL E LTD0 citations52
US10927149B2Feb 23, 2021
Industrially scalable process for recovering biologically active recombinant carrier proteins
BIOLOGICAL E LTD0 citations41
US11299558B2Apr 12, 2022
Process for the preparation of low molecular weight heparin
BIOLOGICAL E LTD0 citations36